CN Patent

CN113683572A — 噁拉戈利的中间体及其制备方法和应用

Assigned to Individual · Expires 2021-11-23 · 4y expired

What this patent protects

本发明提供了一种制备噁拉戈利的关键中间体1的新方法，同时提供了几种新中间体化合物。通过新的中间体和制备方法，不仅大大降低了原料和合成成本，而且收率也得到了大大提高。同时，反应能耗低、“三废”少、反应条件温和，更易于工业化放大生产。

USPTO Abstract

本发明提供了一种制备噁拉戈利的关键中间体1的新方法，同时提供了几种新中间体化合物。通过新的中间体和制备方法，不仅大大降低了原料和合成成本，而且收率也得到了大大提高。同时，反应能耗低、“三废”少、反应条件温和，更易于工业化放大生产。

Drugs covered by this patent

Patent Metadata

Patent number: CN113683572A
Jurisdiction: CN
Classification: —
Expires: 2021-11-23
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.